The Pharma Perspective – Détails, épisodes et analyse

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

The Pharma Perspective

Mirko von Hein

Sciences

Forme & Santé

Fréquence : 1 épisode/45j. Total Éps: 9

The Pharma Perspective brings you clear, insightful conversations on the ideas, challenges, and innovations shaping the pharmaceutical industry. From health economics and market access to clinical evidence and policy, this podcast explores the perspectives that matter for anyone working in or around pharma. Whether you're a consultant, researcher, or industry professional, you'll gain practical insights and a deeper understanding of how the pieces of the pharma world fit together. Hosted by Mirko von Hein, The Pharma Perspective cuts through complexity and shares viewpoints that help you stay informed, think critically, and succeed in the world of pharma. LinkedIn: https://www.linkedin.com/in/mirkovonhein/ YouTube: https://www.youtube.com/@MirkovonHein Instagram: https://www.instagram.com/mirkovonhein

Lire plusRéduire

Site

RSS

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Apple Podcasts

Aucun classement récent disponible

Spotify

Aucun classement récent disponible

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://www.linkedin.com/in/mirkovonhein/
1 partage

https://www.youtube.com/@MirkovonHein
1 partage

https://www.instagram.com/mirkovonhein
1 partage

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Qualité du flux RSS

À améliorer

Score global : 69%

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Year

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

Pharma's Worst Job Market in 30 Years: Top Recruiter Reveals What to Do Now | Grant Coren | EP 7

Saison 1 · Épisode 7

mardi 14 avril 2026 • Durée 01:08:35

In this episode of The Pharma Perspective podcast, Grant Coren, life science recruiter with over 30 years of experience and founder of his own executive search practice, discusses the state of the pharma job market in 2026, why hiring has slowed across pharma, biotech, and CRO alike, how AI screening tools and applicant tracking systems are changing — and distorting — the recruitment process, why most CVs fail to differentiate candidates and what to do instead, the ethical problems with how many recruiters operate and how job seekers should navigate that, the difference between retained executive search and contingency recruitment, how indirect referencing allows recruiters to vet candidates outside of formal references, why loyalty is no longer rewarded in pharma careers and when job-hopping actually accelerates progression, the personality traits that predict success in different pharma roles, the real impact of ageism in life sciences hiring, and why getting your first job in the industry remains the hardest step of all.

Lire plusRéduire

Rethinking Medications: From Academic Detailing to Broken Drug Regulation | Jerry Avorn | EP 6

Saison 1 · Épisode 6

jeudi 15 janvier 2026 • Durée 01:05:23

In this episode of The Pharma Perspective podcast, Jerry Avorn, Professor of Medicine at Harvard Medical School and author of "Rethinking Medications," discusses the state of drug regulation in the United States, the problems with accelerated approvals and missing confirmatory trials, how academic detailing can change prescribing behavior more effectively than guidelines, the misuse of surrogate endpoints in drug development, why weak FDA enforcement actually harms pharmaceutical innovation, the absence of cost-effectiveness analysis and health technology assessment in US drug policy, and where he sees hope for reform through state-level drug policy coalitions and evidence-based prescribing initiatives.

Lire plusRéduire

Measuring What Patients Actually Care About | Katja Rüdell | EP 5

Saison 1 · Épisode 5

jeudi 15 janvier 2026 • Durée 01:15:14

In this episode of The Pharma Perspective podcast, Katja Rüdell, one of the world's leading clinical outcome assessment and patient-reported outcomes experts, discusses the role of PROs in drug development, regulatory expectations from FDA and EMA for outcome measure validation, the challenges of developing fit-for-purpose COA instruments, the evolution of patient-centred research in pharmaceutical clinical trials, and best practices for ensuring PRO data meets both regulatory and clinical standards.

Lire plusRéduire

What Does the ABPI Actually Do? | Jack Neill-Hall | EP 4

Saison 1 · Épisode 4

dimanche 7 décembre 2025 • Durée 37:07

In this episode of The Pharma Perspective podcast, Jack Neill-Hall from the Association of the British Pharmaceutical Industry (ABPI) discusses the UK pharmaceutical pricing environment, NICE's cost-effectiveness threshold and appraisal process for NHS medicines, industry transparency through the Code of Practice and Disclosure UK, healthcare budget allocation, and why some medicines never reach UK assessment.

Lire plusRéduire

Is Raising the NICE Threshold Bad for NHS Patients? | Karl Claxton | EP 3

Saison 1 · Épisode 3

dimanche 7 décembre 2025 • Durée 53:30

In this episode of "The Pharma Perspective", I speak with Karl Claxton, Professor of Economics at the University of York and founding NICE Appraisal Committee member, about his open letter to the UK Prime Minister on pharmaceutical pricing for branded medicines, why raising the NICE willingness-to-pay threshold would be catastrophic for NHS patients, and his proposals for fundamentally reforming health technology assessment and how we value pharmaceutical innovation. 💷🏥

Lire plusRéduire

Starting a Pharma Consultancy in a Pandemic: The PharmacoEvidence Story | Barinder Singh | EP 2

Saison 1 · Épisode 2

mardi 28 octobre 2025 • Durée 01:11:57

Join me in my discussion with Barinder Singh, Founder of PharmacoEvidence, who quit his stable HEOR job in 2020—amid a pandemic and with a baby on the way—to start his own consultancy.

In this episode of The Pharma Perspective, we explore how that bold decision turned into a thriving 40+ person company leading NICE submissions with AI-validated methods.

We also talk about what it really takes to build an HEOR consultancy, the subjectivity in NICE appraisals, and how AI is reshaping evidence synthesis.

A conversation about timing, risk, and self-awareness you won't want to miss.

Lire plusRéduire

How to Build a Meaningful Pharma Career – Leadership Lessons from a GM | Peter Wickersham | EP 1

Saison 1 · Épisode 1

dimanche 17 août 2025 • Durée 50:39

Join me in my discussion with Peter Wickersham, Pharma Vice President & General Manager with 25+ years of experience, as we explore leadership, career growth, and navigating the evolving pharma industry in the age of AI.

In this episode of Pharma Perspectives, Peter shares his insights on the challenges and opportunities shaping pharma today, offering practical advice for professionals interested in health economics, strategy, and the future of healthcare.

Whether you're a healthcare professional, consultant, or simply curious about how the pharma world works behind the scenes, this conversation is packed with actionable insights and thought-provoking ideas.

Lire plusRéduire

Most Favored Nation Pricing, Tariffs & the Rise of China | Neil Grubert | EP 8

Saison 1 · Épisode 8

lundi 27 juillet 2026 • Durée 01:16:37

Most Favored Nation (MFN) drug pricing, pharma tariffs, and China overtaking the US in new drug launches: on this episode of The Pharma Perspective, market access and policy expert Neil Grubert breaks down the forces reshaping how the world prices and pays for medicines. Neil explains what Trump's Executive Order on Most Favored Nation pricing really means, why the US funds an estimated 75% of global pharmaceutical profits, and how tariffs are being used to pressure drug companies and governments. He also unpacks the EU Pharmaceutical Package, Europe's growing launch hesitancy, and the moment when China overtook the US in new medicines brought to market, before closing on what he would change about global drug pricing. Essential viewing for anyone in pharma, market access, HEOR, health policy, or life sciences.

Lire plusRéduire

Will AI Replace Medical Writers? | Virginia Chachati | EP 9

Saison 1 · Épisode 9

lundi 10 août 2026 • Durée 01:04:50

Medical writing rates, AI-proof writing tests, and the telltale signs of AI-generated content: on this episode of The Pharma Perspective, pharmacist turned medical writer Virginia Chachati breaks down what it takes to build a writing career in healthcare today. Virginia explains how she went from community pharmacy to creating health videos with the NHS, why copywriting in healthcare comes with strict legal guardrails, and how France and China are regulating who gets to publish health information online. She also unpacks how to break into medical writing in the age of AI, from unpaid writing tests to pricing your work in the thousands rather than by the hour, and why marketing yourself matters as much as your skill, before closing on personal versus professional branding and what she's building next. Essential viewing for anyone in medical writing, medical communications, pharmacy, health content creation, or life sciences.

Lire plusRéduire

Podcasts Similaires Basées sur le Contenu

Découvrez des podcasts liées à The Pharma Perspective. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !

À propos Méthodologie Contact Me soutenir Politique de confidentialité

The Pharma Perspective – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

LinkedIn1

Youtube1

Instagram1

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Apple Podcasts

Spotify

LinkedIn1

Youtube1

Instagram1

Podcasts Similaires Basées sur le Contenu